Demonstrates tumor suppression in tongue squamous cell carcinoma via miR-302 targeting P65, implying a new therapeutic approach.
Tongue squamous cell carcinoma (TSCC) is an aggressive malignancy with a poor prognosis. The miR-302 family of microRNAs regulates stemness and differentiation, but its role in TSCC remains unknown. Here, we report that miR-372-3p, miR-302c-3p, and miR-520a-3p function as potent tumor suppressors in TSCC. These miRNAs inhibited cell proliferation, clonogenic growth, and induced apoptosis in vitro and in vivo. Transcriptomic analysis revealed that miR-302 overexpression silences pro-survival and inflammatory pathways. We found that these miRNAs directly target the NF-κB subunit P65 (RELA), which is upregulated in TSCC. Knockdown of P65 recapitulated the tumor-suppressive effects of miR-302, whereas P65 reconstitution partially rescued apoptosis and growth inhibition caused by miR-302. Both P65 knockdown and miR-302 overexpression dramatically slowed tumor growth in vivo. Our results demonstrate the therapeutic potential of a novel miR-302/P65 axis that limited the progression of TSCC by regulating apoptosis and oncogenic transcription.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: